Emergency Department Processes for the Evaluation and Management of Persons under Investigation for Ebola Virus Disease

Michael Charles Wadman, Shelly S. Schwedhelm, Suzanne Watson, John Swanhorst, Shawn G. Gibbs, John-Martin J Lowe, Peter Charles Iwen, A. Kim Hayes, Susie Needham, Daniel W Johnson, Daniel J. Kalin, Wesley G Zeger, Robert Leo Muelleman

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Introduction Due to the recent Ebola virus outbreak in West Africa, patients with epidemiologic risk for Ebola virus disease and symptoms consistent with Ebola virus disease are presenting to emergency departments (EDs) and clinics in the United States. These individuals, identified as a person under investigation for Ebola virus disease, are initially screened using a molecular assay for Ebola virus. If this initial test is negative and the person under investigation has been symptomatic for < 3 days, a repeat test is required after 3 days of symptoms to verify the negative result. In the time interval before the second test result is available, manifestations of the underlying disease process for the person under investigation, whether due to Ebola virus disease or some other etiology, may require further investigation to direct appropriate therapy. Materials and Methods ED administrators, physicians, and nurses proposed processes to provide care that is consistent with other ED patients. Biocontainment unit administrators, industrial hygienists, laboratory directors, physicians, and other medical personnel examined the ED processes and offered biocontainment unit personal protective equipment and process strategies designed to ensure safety for providers and patients. Conclusion ED processes for the safe and timely evaluation and management of the person under investigation for Ebola virus disease are presented with the ultimate goals of protecting providers and ensuring a consistent level of care while confirmatory testing is pending.

Original languageEnglish (US)
Pages (from-to)306-314
Number of pages9
JournalAnnals of emergency medicine
Volume66
Issue number3
DOIs
StatePublished - Sep 1 2015

Fingerprint

Ebola Hemorrhagic Fever
Hospital Emergency Service
Ebolavirus
Physicians
Nurse Administrators
Western Africa
Patient Safety
Administrative Personnel
Disease Outbreaks

ASJC Scopus subject areas

  • Emergency Medicine

Cite this

Emergency Department Processes for the Evaluation and Management of Persons under Investigation for Ebola Virus Disease. / Wadman, Michael Charles; Schwedhelm, Shelly S.; Watson, Suzanne; Swanhorst, John; Gibbs, Shawn G.; Lowe, John-Martin J; Iwen, Peter Charles; Hayes, A. Kim; Needham, Susie; Johnson, Daniel W; Kalin, Daniel J.; Zeger, Wesley G; Muelleman, Robert Leo.

In: Annals of emergency medicine, Vol. 66, No. 3, 01.09.2015, p. 306-314.

Research output: Contribution to journalReview article

@article{8bdc5299ac1c4204a5393667a23e6e40,
title = "Emergency Department Processes for the Evaluation and Management of Persons under Investigation for Ebola Virus Disease",
abstract = "Introduction Due to the recent Ebola virus outbreak in West Africa, patients with epidemiologic risk for Ebola virus disease and symptoms consistent with Ebola virus disease are presenting to emergency departments (EDs) and clinics in the United States. These individuals, identified as a person under investigation for Ebola virus disease, are initially screened using a molecular assay for Ebola virus. If this initial test is negative and the person under investigation has been symptomatic for < 3 days, a repeat test is required after 3 days of symptoms to verify the negative result. In the time interval before the second test result is available, manifestations of the underlying disease process for the person under investigation, whether due to Ebola virus disease or some other etiology, may require further investigation to direct appropriate therapy. Materials and Methods ED administrators, physicians, and nurses proposed processes to provide care that is consistent with other ED patients. Biocontainment unit administrators, industrial hygienists, laboratory directors, physicians, and other medical personnel examined the ED processes and offered biocontainment unit personal protective equipment and process strategies designed to ensure safety for providers and patients. Conclusion ED processes for the safe and timely evaluation and management of the person under investigation for Ebola virus disease are presented with the ultimate goals of protecting providers and ensuring a consistent level of care while confirmatory testing is pending.",
author = "Wadman, {Michael Charles} and Schwedhelm, {Shelly S.} and Suzanne Watson and John Swanhorst and Gibbs, {Shawn G.} and Lowe, {John-Martin J} and Iwen, {Peter Charles} and Hayes, {A. Kim} and Susie Needham and Johnson, {Daniel W} and Kalin, {Daniel J.} and Zeger, {Wesley G} and Muelleman, {Robert Leo}",
year = "2015",
month = "9",
day = "1",
doi = "10.1016/j.annemergmed.2015.04.020",
language = "English (US)",
volume = "66",
pages = "306--314",
journal = "Annals of Emergency Medicine",
issn = "0196-0644",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Emergency Department Processes for the Evaluation and Management of Persons under Investigation for Ebola Virus Disease

AU - Wadman, Michael Charles

AU - Schwedhelm, Shelly S.

AU - Watson, Suzanne

AU - Swanhorst, John

AU - Gibbs, Shawn G.

AU - Lowe, John-Martin J

AU - Iwen, Peter Charles

AU - Hayes, A. Kim

AU - Needham, Susie

AU - Johnson, Daniel W

AU - Kalin, Daniel J.

AU - Zeger, Wesley G

AU - Muelleman, Robert Leo

PY - 2015/9/1

Y1 - 2015/9/1

N2 - Introduction Due to the recent Ebola virus outbreak in West Africa, patients with epidemiologic risk for Ebola virus disease and symptoms consistent with Ebola virus disease are presenting to emergency departments (EDs) and clinics in the United States. These individuals, identified as a person under investigation for Ebola virus disease, are initially screened using a molecular assay for Ebola virus. If this initial test is negative and the person under investigation has been symptomatic for < 3 days, a repeat test is required after 3 days of symptoms to verify the negative result. In the time interval before the second test result is available, manifestations of the underlying disease process for the person under investigation, whether due to Ebola virus disease or some other etiology, may require further investigation to direct appropriate therapy. Materials and Methods ED administrators, physicians, and nurses proposed processes to provide care that is consistent with other ED patients. Biocontainment unit administrators, industrial hygienists, laboratory directors, physicians, and other medical personnel examined the ED processes and offered biocontainment unit personal protective equipment and process strategies designed to ensure safety for providers and patients. Conclusion ED processes for the safe and timely evaluation and management of the person under investigation for Ebola virus disease are presented with the ultimate goals of protecting providers and ensuring a consistent level of care while confirmatory testing is pending.

AB - Introduction Due to the recent Ebola virus outbreak in West Africa, patients with epidemiologic risk for Ebola virus disease and symptoms consistent with Ebola virus disease are presenting to emergency departments (EDs) and clinics in the United States. These individuals, identified as a person under investigation for Ebola virus disease, are initially screened using a molecular assay for Ebola virus. If this initial test is negative and the person under investigation has been symptomatic for < 3 days, a repeat test is required after 3 days of symptoms to verify the negative result. In the time interval before the second test result is available, manifestations of the underlying disease process for the person under investigation, whether due to Ebola virus disease or some other etiology, may require further investigation to direct appropriate therapy. Materials and Methods ED administrators, physicians, and nurses proposed processes to provide care that is consistent with other ED patients. Biocontainment unit administrators, industrial hygienists, laboratory directors, physicians, and other medical personnel examined the ED processes and offered biocontainment unit personal protective equipment and process strategies designed to ensure safety for providers and patients. Conclusion ED processes for the safe and timely evaluation and management of the person under investigation for Ebola virus disease are presented with the ultimate goals of protecting providers and ensuring a consistent level of care while confirmatory testing is pending.

UR - http://www.scopus.com/inward/record.url?scp=84940453510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940453510&partnerID=8YFLogxK

U2 - 10.1016/j.annemergmed.2015.04.020

DO - 10.1016/j.annemergmed.2015.04.020

M3 - Review article

C2 - 26003001

AN - SCOPUS:84940453510

VL - 66

SP - 306

EP - 314

JO - Annals of Emergency Medicine

JF - Annals of Emergency Medicine

SN - 0196-0644

IS - 3

ER -